Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance...
Guardado en:
Autores principales: | Mendes LC, Stucchi RSB, Vigani AG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identifying High-Risk NASH Patients: What We Know so Far
por: Schulz M, et al.
Publicado: (2020) -
“Let my liver rather heat with wine” - a review of hepatic fibrosis pathophysiology and emerging therapeutics
por: Moscoso CG, et al.
Publicado: (2019) -
Hepatitis C in the Russian Federation: challenges and future directions
por: Mukomolov S, et al.
Publicado: (2016) -
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
por: Serra JT, et al.
Publicado: (2020) -
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
por: Ismail MH, et al.
Publicado: (2011)